微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 4.85% | -35.76% | 64.97% | 65/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.94% | -33.63% | 58.06% | 64/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.86% | -24.39% | -67.37% | 59/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 5.7% | -20.17% | -24.5% | 54/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 7.55% | -4.43% | 70.43% | 44/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.43% | -10.69% | 80.08% | 44/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.46% | -6.46% | -65.55% | 50/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 7.14% | 25.48% | -9.62% | 46/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.9% | 4.08% | 59.27% | 41/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.96% | 34.42% | 88.59% | 41/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.63% | 24.64% | -53.78% | 46/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.69% | 19.79% | -25.03% | 69/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 7.59% | 22.82% | 105.69% | 48/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.69% | 20.2% | 74.88% | 60/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.11% | 10.47% | -55.58% | 54/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.75% | 13.1% | -23.14% | 79/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 6.18% | 18.39% | 101.3% | 65/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.07% | 7.72% | 60.73% | 77/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.91% | 19.38% | -54.52% | 68/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.2% | 29.63% | -19.54% | 89/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 5.22% | -9.38% | 83.16% | 69/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.85% | -5.94% | 78.13% | 75/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.6% | 25% | -50.62% | 59/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.24% | -7.95% | -43.75% | 99/158 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.76% | 28% | 90.1% | 61/158 | 7.53% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.03% | 0.33% | 136.72% | 70/158 | 5% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.28% | 36.17% | -63.64% | 76/158 | 2.43% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.52% | -14.36% | -21.78% | 100/158 | 7.17% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.5% | -12.11% | 49.01% | 74/158 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.02% | 23.77% | 221.28% | 67/158 | 4.64% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.94% | 16.05% | -77.13% | 79/158 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.11% | 25.3% | -19.73% | 91/158 | 9.68% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.12% | 36.17% | 109.84% | 63/158 | 8.34% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.44% | 37.85% | 201.23% | 77/158 | 5.62% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.81% | 39.66% | -75.3% | 65/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 3.28% | 73.54% | -12.77% | 89/158 | 6.22% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.76% | 31.47% | 112.43% | 59/158 | 5.64% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 1.77% | 46.28% | 205.17% | 70/158 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.58% | 0% | -69.31% | 70/158 | 2.69% | 贝达药业 | 16.78% | 行业排名> |